• symphony

    Edition 102

  • jublient

    April-2023

IN THE NEWS

Jubilant Therapeutics Inc.’s Selective, Orally Administered PAD4 Inhibitor Demonstrates Activity in Rheumatoid Arthritis Preclinical Models

Jubilant Therapeutics Inc., recently announced publication of novel research demonstrating that a highly selective, non-competitive and orally administered inhibitor of Protein Arginine Deiminase 4 (PAD4), showed remarkable efficacy in two animal models of Rheumatoid Arthritis (RA). Correlative in vitro studies confirmed that PAD4 inhibition acts by inhibiting NETosis, a fundamental pathophysiological mechanism in the establishment of many autoimmune diseases. The research was conducted in collaboration with Prof. Denisa Wagner a pioneer in PAD4 target space, at the Boston Children’s Hospital. The research was published in Scientific Reports

Click here to read more

image

Applications open for the Prestigious ‘Social Entrepreneur of the Year (SEOY) - India Award 2023

Our CSR arm, Jubilant Bhartia Foundation and Schwab Foundation for Social Entrepreneurship, the sister organisation of the World Economic Forum, recently opened  applications for the 14th edition of the annual competition - Social Entrepreneur of the Year (SEOY) India Award 2023. The application entry for the award will be accepted till April 30, 2023. The winner of the Social Entrepreneur of the Year (SEOY) India Award 2023 will be announced in the last week of August, 2023 by an eminent personality in a magnificent ceremony at New Delhi.

Click here to read more

image

CPHI Japan 2023

The 2023 edition of CPHI Japan was special as the physical exhibition was happening after a gap of three years. Jubilant Biosys Limited participated in this prestigious exhibition at Tokyo Big Sight in Tokyo, Japan from 19-21 April.

Four representatives from the company were present to showcase the business capabilities, product offerings and hosted the clients/visitors. The team discussed the bespoke business solutions, future growth prospects and profitable business opportunities. The team also utilized this platform for networking with fellow professionals who were present from different parts of the globe.

image